Suchergebnisse - "Cariou, Bertrand"

PubPharm (472)

281

Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial

enthalten in: Diabetes care | 2016

von Nauck, M. | Rizzo, M. | Johnson, A. | +3

282

FGF21 Improves the Adipocyte Dysfunction Related to Seipin-Deficiency

enthalten in: Diabetes | 2016

von Dollet, L. | Levrel, C. | Coskun, T. | +9

283

Efficacy of lixisenatide in patients with type 2 diabetes: A post hoc analysis of patients with diverse β-cell function in the GetGoal-M and GetGoal-S trials

enthalten in: Journal of diabetes and its complications | 2016

von Yabe, D. | Ambos, A. | Cariou, B. | +8

284

PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering

enthalten in: Atherosclerosis | 2016

von Cariou, B. | Ding, Z. | Mehta, J.

285

FGF21 Improves the Adipocyte Dysfunction Related to Seipin Deficiency

enthalten in: Diabetes | 2016

von Dollet, L. | Levrel, C. | Coskun, T. | +9

286

Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials

enthalten in: International journal of cardiology | 2016

von Farnier, M. | Gaudet, D. | Valcheva, V. | +3

287

No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies

enthalten in: European heart journal | 2016

von Colhoun, H. | Ginsberg, H. | Robinson, J. | +8

288

Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naïve subjects with type 2 diabetes (SUSTAIN 4)

enthalten in: Diabetes research and clinical practice | 2016

von Aroda, V. | Bain, S. | Cariou, B. | +5

289

Impact of Sleeve Gastrectomy on Intestinal Permeability in Diet-Induced Obese Mice

enthalten in: Surgery for obesity and related diseases | 2016

von Blanchard, c. | Ayer, A. | Chevalier, J. | +7

290

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody

enthalten in: Circulation. Cardiovascular genetics | 2015

von Hopkins, P. | Defesche, J. | Fouchier, S. | +39

CommentIn: Circ Cardiovasc Genet. 2015 Dec;8(6):749-51. - PMID 26671969